Table 11 LOD and LOQ study of Tezacaftor and Ivacaftor in mobile phase and human plasma
Name of the drug | Mobile phase | Human plasma | ||
|---|---|---|---|---|
LOD(μg/mL) | LOQ(μg/mL) | LOD(μg/mL) | LOQ(μg/mL) | |
Tezacaftor | 0.011 | 0.03 | 0.09 | 0.275 |
Ivacaftor | 0.115 | 0.349 | 0.31 | 0.96 |
Name of the drug | Mobile phase | Human plasma | ||
|---|---|---|---|---|
LOD(μg/mL) | LOQ(μg/mL) | LOD(μg/mL) | LOQ(μg/mL) | |
Tezacaftor | 0.011 | 0.03 | 0.09 | 0.275 |
Ivacaftor | 0.115 | 0.349 | 0.31 | 0.96 |